SHMT inhibitor synergizes with 5-Fu to suppress gastric cancer via cell cycle arrest and chemoresistance alleviation
Abstract Advanced gastric cancer (GC) represents a malignancy tumor with poor prognosis, which requires urgent exploration into its molecular drivers and innovative therapeutic strategies. This study investigates the oncogenic role of serine hydroxymethyltransferase isoforms (SHMT1/SHMT2), key regul...
Saved in:
| Main Authors: | Huan Deng, Yajie Wang, Lin Xiao, Mei Feng, Weidong Dou, Yisheng Pan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-00926-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting CBP revers chemoresistance to 5‐FU of CDX2/REG4 double‐positive gastric cancer
by: Zhiyuan Fan, et al.
Published: (2024-11-01) -
PHGDH drives 5-FU chemoresistance in colorectal cancer through the Hedgehog signaling
by: Caterina Mancini, et al.
Published: (2025-07-01) -
TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer
by: Chunye Huang, et al.
Published: (2025-04-01) -
Targeted inhibition of Ninjurin2 promotes chemosensitivity in chemoresistant gastric cancer by suppressing cancer-initiating cells
by: Hyo Shik Shin, et al.
Published: (2025-06-01) -
Upregulated Expression of SHMT2 Predicts Poor Survival of Lung Adenocarcinoma
by: Qi Guo, et al.
Published: (2025-01-01)